Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial

MASTER DAPT Investigators, Pieter C Smits, Enrico Frigoli, Jan Tijssen, Peter Jüni, Pascal Vranckx, Yukio Ozaki, Marie-Claude Morice, Bernard Chevalier, Yoshinobu Onuma, Stephan Windecker, Pim A L Tonino, Marco Roffi, Maciej Lesiak, Felix Mahfoud, Jozef Bartunek, David Hildick-Smith, Antonio Colombo, Goran Stankovic, Andres IñiguezCarl Schultz, Ran Kornowski, Paul J L Ong, Mirvat Alasnag, Alfredo E Rodriguez, Aris Moschovitis, Peep Laanmets, Dik Heg, Marco Valgimigli

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science